AZD 3147

AZD 3147 是一种 mTORC 抑制剂,对 mTORC1 和 mTORC2 的 IC50 分别为 40.7 和 5.75 nM。 AZD 3147 对 PI3Kα、PI3Kβ、PI3Kδ 和 PI3Kγ 的 IC50 值分别为 912、5495、9333 和 6310 nM。

CAS号

1101810-02-9

分子式

C24H31N5O4S2

主要靶点

mTOR

仅限科研使用

Cat No : CM10486

Print datasheet

Synonyms



产品信息

AZD 3147 is an inhibitor of mTORC with IC50s of 40.7 and 5.75 nM for mTORC1 and mTORC2. AZD 3147 shows IC50s of 912, 5495, 9333, and 6310 nM for PI3Kα, PI3Kβ, PI3Kδ, and PI3Kγ, respectively.

CAS号 1101810-02-9
分子式 C24H31N5O4S2
主要靶点 mTOR
主要通路 PI3K/Akt/mTOR信号通路
分子量 517.66
纯度 98.34%, 此纯度可做参考,具体纯度与批次有关系,可咨询客服
储存条件 Powder: -20°C for 3 years | In solvent: -80°C for 1 year
别名

体内活性

AZD3147 shows a CL of 78 mL/min/kg, a Vss of 2.3 L/kg, a t1/2 of 0.9 h and an F of 61% in mice[1].

体外活性

In NIH3T3 cells, AZD3147 (1.5-50 nM) alleviates FGF-mediated cilia extension[2]. AZD3147 inhibits cell viability of neuroblastoma cell lines Kelly(IC50 = 0.88 nM) and IMR-32 (IC50 = 662.4 nM)[3].

溶解度

Hydrochloride acid:100 nM,DMSO:46.8 mg/mL (90.5 mM),Ethanol:1 mg/mL

参考文献

1.Pike, K.G., Morris, J., Ruston, L., et al. Discovery of AZD3147: A potent, selective dual inhibitor of mTORC1 and mTORC2. J. Med. Chem. 58(5), 2326-2349 (2015). AZD 3147
2.Michaela Kunova Bosakova, et al. Regulation of ciliary function by fibroblast growth factor signaling identifies FGFR3-related disorders achondroplasia and thanatophoric dysplasia as ciliopathies. Hum Mol Genet. 2018 Mar 15;27(6):1093-1105.
3.Rebecca Waetzig, et al. Comparing mTOR inhibitor Rapamycin with Torin-2 within the RIST molecular-targeted regimen in neuroblastoma cells. Int J Med Sci. 2021 Jan 1;18(1):137-149.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
=
×
×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
×
=
×
C1   V1   C2   V2